Dimethylthiourea normalizes velocity-dependent, but not force-dependent, index of ventricular performance in diabetic rats: Role of myosin heavy chain isozyme

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 297, Issue 4, 2009, Pages

  Yeih, Dong Feng ^a   Yeh, Hung I ^b,c,d   Hsin, Ho Tsung ^a   Lin, Lian Yu ^e   Chiang, Fu Tien ^e   Tseng, Chuen Den ^e   Chu, Shu Hsun ^a   Tseng, Yung Zu ^e  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c MACKAY MEDICAL COLLEGE   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Antioxidant; Contractile function; Myocyte enhancer factor 2; Oxidative stress; Transcription factor

Indexed keywords

DIMETHYLTHIOUREA; ISOENZYME; MYOCYTE ENHANCER FACTOR 2; MYOSIN HEAVY CHAIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HEART MUSCLE CONTRACTILITY; HEMODYNAMICS; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARDIOVASCULAR AGENTS; DIABETES MELLITUS, EXPERIMENTAL; ELASTICITY; FREE RADICAL SCAVENGERS; HEMODYNAMICS; HYDROXYL RADICAL; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOGENIC REGULATORY FACTORS; MYOSIN HEAVY CHAINS; OXIDATIVE STRESS; PROTEIN ISOFORMS; RATS; RATS, WISTAR; THIOUREA; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 70349616673     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01269.2008     Document Type: Article

References (61)

1. Akazawa H, Komuro I. Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res 92: 1079-1088, 2003. (Pubitemid 36665853)
2. Alpert NR, Mulieri LA, Litten RZ. Functional significance of altered myosin adenosine triphosphatase activity in enlarged hearts. Am J Cardiol 44: 946-953, 1979.
3. An D, Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 291: H1489-H1506, 2006. (Pubitemid 44497651)
4. Aragno M, Mastrocola R, Medana C, Catalano MG, Vercellinatto I, Danni O, Boccuzzi G. Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes. Endocrinology 147: 5967-5974, 2006. (Pubitemid 44833515)
5. Backs J, Olson EN. Control of cardiac growth by histone acetylation/ deacetylation. Circ Res 98: 15-24, 2006. (Pubitemid 43977219)
6. Bar H, Kreuzer J, Cojoc A, Jahn L. Upregulation of embryonic transcription factors in right ventricular hypertrophy. Basic Res Cardiol 98: 285-294, 2003. (Pubitemid 37107655)
7. Belcher P, Boerboom LE, Olinger GN. Standardization of end-systolic pressure-volume relation in the dog. Am J Physiol Heart Circ Physiol 249: H547-H553, 1985.
8. Black BL, Olson EN. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol 14: 167-196, 1998.
9. Blough ER, Rennie ER, Zhang F, Reiser PJ. Enhanced electrophoretic separation and resolution of myosin heavy chains in mammalian and avian skeletal muscles. Anal Biochem 233: 31-35, 1996. (Pubitemid 26036361)
10. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 356: 1213-1218, 2000. (Pubitemid 30769486)
11. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation 115: 3213-3223, 2007.
12. Cai L, Kang YJ. Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovasc Toxicol 1: 181-193, 2001. (Pubitemid 37013746)
13. Cai L, Wang Y, Zhou G, Chen T, Song Y, Li X, Kang YJ. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J Am Coll Cardiol 48: 1688-1697, 2006. (Pubitemid 44528172)
14. Campbell KB, Ringo JA, Knowlen GG, Kirkpatrick RD, Schmidt SL. Validation of optional elastance-resistance left ventricle pump models. Am J Physiol Heart Circ Physiol 251: H382-H397, 1986.
15. Carbonell LF, Salom MG, Garcia-Estan J, Salazar FJ, Ubeda M, Quesada T. Hemodynamic alterations in chronically conscious unrestrained diabetic rats. Am J Physiol Heart Circ Physiol 252: H900-H905, 1987. (Pubitemid 17080703)
16. Carrea FP, Lesnefsky EJ, Repine JE, Shikes RH, Horwitz LD. Reduction of canine myocardial infarct size by a diffusible reactive oxygen metabolite scavenger. Efficacy of dimethylthiourea given at the onset of reperfusion. Circ Res 68: 1652-1659, 1991.
17. Czubryt MP, Olson EN. Balancing contractility and energy production: the role of myocyte enhancer factor 2 (MEF2) in cardiac hypertrophy. Recent Prog Horm Res 59: 105-124, 2004.
18. Feng B, Chen S, Chiu J, George B, Chakrabarti S. Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level. Am J Physiol Endocrinol Metab 294: E1119-E1126, 2008.
19. Gupta M, Sueblinvong V, Raman J, Jeevanandam V, Gupta MP. Single-stranded DNA-binding proteins PURalpha and PURbeta bind to a purine-rich negative regulatory element of the alpha-myosin heavy chain gene and control transcriptional and translational regulation of the gene expression. Implications in the repression of alpha-myosin heavy chain during heart failure. J Biol Chem 278: 44935-44948, 2003. (Pubitemid 37377253)
20. How OJ, Aasum E, Severson DL, Chan WY, Essop MF, Larsen TS. Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. Diabetes 55: 466-473, 2006. (Pubitemid 43343277)
21. Hunter WC, Janicki JS, Weber KT, Noordergraaf A. Systolic mechanical properties of the left ventricle. Effects of volume and contractile state. Circ Res 52: 319-327, 1983. (Pubitemid 13158747)
22. Sagawa K, Mauchan L, Suga H, Sunagawa K. Effects of growth and aging of organism on ESPVR: normalization of Ees for heart size. In: Cardiac Contraction and the Pressure-Volume Relationship. New York: Oxford, 1988, p. 352-353.
23. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34: 29-34, 1974.
24. Kinugawa S, Tsutsui H, Hayashidani S, Ide T, Suematsu N, Satoh S, Utsumi H, Takeshita A. Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress. Circ Res 87: 392-398, 2000. (Pubitemid 30688989)
25. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
26. Litwin SE, Raya TE, Daugherty S, Goldman S. Peripheral circulatory control of cardiac output in diabetic rats. Am J Physiol Heart Circ Physiol 261: H836-H842, 1991.
27. Meldrum DR, Shenkar R, Sheridan BC, Cain BS, Abraham E, Harken AH. Hemorrhage activates myocardial NFkappaB and increases TNF-alpha in the heart. J Mol Cell Cardiol 29: 2849-2854, 1997. (Pubitemid 27466506)
28. Mercadier JJ, Lompre AM, Wisnewsky C, Samuel JL, Bercovici J, Swynghedauw B, Schwartz K. Myosin isoenzyme changes in several models of rat cardiac hypertrophy. Circ Res 49: 525-532, 1981. (Pubitemid 11053314)
29. Molkentin JD, Markham BE. Myocyte-specific enhancer-binding factor (MEF-2) regulates alpha-cardiac myosin heavy chain gene expression in vitro and in vivo. J Biol Chem 268: 19512-19520, 1993. (Pubitemid 23270734)
30. Nagareddy PR, Vasudevan H, McNeill JH. Oral administration of sodium tungstate improves cardiac performance in streptozotocin-induced diabetic rats. Can J Physiol Pharmacol 83: 405-411, 2005. (Pubitemid 41003315)
31. Natarajan A, Yamagishi H, Ahmad F, Li D, Roberts R, Matsuoka R, Hill S, Srivastava D. Human eHAND, but not dHAND, is down-regulated in cardiomyopathies. J Mol Cell Cardiol 33: 1607-1614, 2001. (Pubitemid 32844219)
32. Norby FL, Wold LE, Duan J, Hintz KK, Ren J. IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes. Am J Physiol Endocrinol Metab 283: E658-E666, 2002. (Pubitemid 35050803)
33. Passier R, Zeng H, Frey N, Naya FJ, Nicol RL, McKinsey TA, Overbeek P, Richardson JA, Grant SR, Olson EN. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J Clin Invest 105: 1395-1406, 2000. (Pubitemid 30322405)
34. Pieper GM, Siebeneich W, Roza AM, Jordan M, Adams MB. Chronic treatment in vivo with dimethylthiourea, a hydroxyl radical scavenger, prevents diabetes-induced endothelial dysfunction. J Cardiovasc Pharmacol 28: 741-745, 1996. (Pubitemid 26412484)
35. Poornima IG, Parikh P, Shannon RP. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res 98: 596-605, 2006. (Pubitemid 43755278)
36. Regan TJ, Lyons MM, Ahmed SS, Levinson GE, Oldewurtel HA, Ahmad MR, Haider B. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 60: 884-899, 1977.
37. Rodrigues B, Xiang H, McNeill JH. Effect of L-carnitine treatment on lipid metabolism and cardiac performance in chronically diabetic rats. Diabetes 37: 1358-1364, 1988. (Pubitemid 19035986)
38. Shroff SG, Janicki JS, Weber KT. Evidence and quantitation of left ventricular systolic resistance. Am J Physiol Heart Circ Physiol 249: H358-H370, 1985. (Pubitemid 16240792)
39. Shroff SG, Naegelen D, Clark WA. Relation between left ventricular systolic resistance and contractile rate processes. Am J Physiol Heart Circ Physiol 258: H381-H394, 1990. (Pubitemid 20103159)
40. Sunagawa K, Maughan WL, Burkhoff D, Sagawa K. Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol Heart Circ Physiol 245: H773-H780, 1983. (Pubitemid 14245481)
41. Sunagawa K, Yamada A, Senda Y, Kikuchi Y, Nakamura M, Shibahara T, Nose Y. Estimation of the hydromotive source pressure from ejecting beats of the left ventricle. IEEE Trans Biomed Eng 27: 299-305, 1980. (Pubitemid 10000793)
42. Tada H, Oida K, Kutsumi Y, Shimada Y, Nakai T, Miyabo S. Effects of probucol on impaired cardiac performance and lipid metabolism in streptozotocin-induced diabetic rats. J Cardiovasc Pharmacol 20: 179-186, 1992.
43. Talmadge RJ, Roy RR. Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms. J Appl Physiol 75: 2337-2340, 1993. (Pubitemid 23352414)
44. Tardiff JC, Hewett TE, Factor SM, Vikstrom KL, Robbins J, Leinwand LA. Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects. Am J Physiol Heart Circ Physiol 278: H412-H419, 2000. (Pubitemid 30131239)
45. Thattaliyath BD, Livi CB, Steinhelper ME, Toney GM, Firulli AB. HAND1 and HAND2 are expressed in the adult-rodent heart and are modulated during cardiac hypertrophy. Biochem Biophys Res Commun 297: 870-875, 2002.
46. Tomlinson KC, Gardiner SM, Hebden RA, Bennett T. Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev 44: 103-150, 1992.
47. Trost SU, Belke DD, Bluhm WF, Meyer M, Swanson E, Dillmann WH. Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes 51: 1166-1171, 2002. (Pubitemid 34438364)
48. Vaartjes SR, Boom HB. Left ventricular internal resistance and unloaded ejection flow assessed from pressure-flow relations: a flow-clamp study on isolated rabbit hearts. Circ Res 60: 727-737, 1987.
49. Van den Bergh A, Flameng W, Herijgers P. Type II diabetic mice exhibit contractile dysfunction but maintain cardiac output by favourable loading conditions. Eur J Heart Fail 8: 777-783, 2006. (Pubitemid 44781425)
50. Vega-Lopez S, Devaraj S, Jialal I. Oxidative stress and antioxidant supplementation in the management of diabetic cardiovascular disease. J Investig Med 52: 24-32, 2004. (Pubitemid 38248892)
51. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: metaanalysis of randomised trials. Lancet 361: 2017-2023, 2003. (Pubitemid 36695043)
52. Wang J, Song Y, Elsherif L, Song Z, Zhou G, Prabhu SD, Saari JT, Cai L. Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation. Circulation 113: 544-554, 2006. (Pubitemid 43754355)
53. Wasil M, Halliwell B, Grootveld M, Moorhouse CP, Hutchison DC, Baum H. The specificity of thiourea, dimethylthiourea and dimethyl sulphoxide as scavengers of hydroxyl radicals. Their protection of alpha 1-antiproteinase against inactivation by hypochlorous acid. Biochem J 243: 867-870, 1987. (Pubitemid 17073729)
54. Westermann D, Rutschow S, Jager S, Linderer A, Anker S, Riad A, Unger T, Schultheiss HP, Pauschinger M, Tschope C. Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism. Diabetes 56: 641-646, 2007. (Pubitemid 46348458)
55. Wiernsperger NF. Oxidative stress as a therapeutic target in diabetes: revisiting the controversy. Diabetes Metab 29: 579-585, 2003.
56. 2+ cycling proteins, NADPH oxidase, poly(ADP-Ribose) polymerase and myosin heavy chain isozyme. Free Radic Biol Med 40: 1419-1429, 2006.
57. Xia Z, Guo Z, Nagareddy PR, Yuen V, Yeung E, McNeill JH. Antioxidant N-acetylcysteine restores myocardial Mn-SOD activity and attenuates myocardial dysfunction in diabetic rats. Eur J Pharmacol 544: 118-125, 2006. (Pubitemid 44148577)
58. Xu J, Gong NL, Bodi I, Aronow BJ, Backx PH, Molkentin JD. Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice. J Biol Chem 281: 9152-9162, 2006. (Pubitemid 43864629)
59. Yeih DF, Lin LY, Yeh HI, Lai YJ, Chiang FT, Tseng CD, Chu SH, Tseng YZ. Temporal changes in cardiac force- and flow-generation capacity, loading conditions, and mechanical efficiency in streptozotocin-induced diabetic rats. Am J Physiol Heart Circ Physiol 294: H867-H874, 2008.
60. Zhou G, Li X, Hein DW, Xiang X, Marshall JP, Prabhu SD, Cai L. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart. J Am Coll Cardiol 52: 655-666, 2008.
61. Ziegler D, Nowak H, Kempler P, Vargha P, Low PA. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 21: 114-121, 2004. (Pubitemid 38221809)